Portfolio company
LUCAI
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
LUCAI provides artificial intelligence solutions for molecular design and clinical diagnostics to pharmaceutical and biotechnology companies.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Lucid Genomics
This company develops an artificial intelligence platform for long-read genomic data interpretation to assist clinical laboratories and pharmaceutical researchers with diagnostics.
Duplicat
This company develops artificial intelligence technology to accelerate molecular discovery and enhance drug compound identification for pharmaceutical businesses.
Chai Discovery
This company develops artificial intelligence models to predict and design molecular structures and protein binders for pharmaceutical and life sciences researchers.
Variartional
This company develops generative artificial intelligence to accelerate the discovery and optimization of novel small molecules for biopharmaceutical researchers and drug developers.
AI-enabled drug design
This company develops generative machine learning platforms to design and optimise small-molecule drug candidates for pharmaceutical and biotechnology partners.
DeepSeq.AI
DeepSeq.AI develops an artificial intelligence platform for protein drug discovery and biologics design for pharmaceutical and biotechnology companies.
DreamFold
This company develops generative AI models for protein design to discover new therapeutic drugs for pharmaceutical researchers and clinicians.
Ionlace
This company develops an artificial intelligence platform for designing and producing novel proteins for the biotechnology and pharmaceutical industries.
